Christian M DregerDr, PhD, EMBA, LLB, MBA, IDP at SWISS Orphan EDC AGPresenter
Profile
Truly accomplished, high performing, people and team-oriented executive in the pharmaceutical, biotech, PE, VC, financial industries with strategic, executional, organizational, motivational and deep financial track records.
Passionate about innovation, drug development, multi-channel commercial models, AI, build ups, performance, competitive edges (time, costs, revenues), value creation for owners towards total EV, EBITA and EBITDA driven.
Uncompromisable ethics & values for long term performance. Led from small to multibillion P&Ls in specialty care, PC, immune-oncology, CV, diabetes, CNS, rare diseases with success. AI-driven R&D and drug development, from 10 to 7.500 employees under own line management. Successfully exceeded regional targets in all three continents, EMEA, North America/USA, Asia Pacific (incl. Japan, China). Led from small, mid-sized to large organizations (120’000 people), 46+ due diligences, many deals, 4 major exits and PE acquisitions. Expert in PE transactions, de-listing NASDAQ, debt financing (placed 2.5 bn USD, SEC NY). Passionate about R&D, breakthrough innovations, launch excellence.
Roche Pharma & Roche Diagnostics, McKinsey, AZ, Merck-SP, Biogen, Parexel USA. Numbers and results driven, empathetic, analytical leader, focusing on people and priorities, excellent value creating negotiator, moderator. 6 languages, 6 + 5 AI diplomas, alumnus of Mannheim, Oxford, St Gallen, Harvard, Kellogg NW, MIT, Stanford, Insead, IMD Lausanne.
Agenda Sessions
Immuno-Oncology: SWISS Orphan EDC AG
, 11:30View Session
